Marine antitumor drugs: status, shortfalls and strategies

Area of Science:

• Marine biology
• Pharmacology
• Oncology

Background:

• Cancer remains a leading cause of mortality, necessitating novel therapeutic strategies.
• Marine natural products offer a largely untapped resource for anticancer drug discovery.
• Existing marine chemotherapy research has advanced understanding of tumor molecular pathways.

Purpose of the Study:

• To review the current status of marine-derived inhibitors targeting cancer signaling pathways.
• To highlight challenges and propose strategies for marine antitumor drug discovery.

Main Methods:

• Literature review of marine natural products with antitumor activity.
• Analysis of marine compounds targeting specific cancer signaling pathways.
• Identification of research gaps and future directions in marine drug discovery.

Main Results:

• Marine environments are rich sources of diverse bioactive compounds with antitumor potential.
• Several marine-derived compounds effectively inhibit key cancer signaling pathways.
• Significant challenges exist in marine drug discovery, including compound isolation and scalability.

Conclusions:

• Marine natural products represent a promising frontier for developing novel anticancer therapeutics.
• Overcoming current shortfalls is crucial for advancing marine antitumor drug discovery.
• Future research should focus on sustainable sourcing and targeted development of marine-derived anticancer agents.